NCT05376202View on ClinicalTrials.gov

Image Guided Penile Cancer Surgery

PHASE1CompletedINTERVENTIONAL

Enrollment

11

Participants

Timeline

Start Date

March 7, 2022

Primary Completion Date

May 1, 2023

Study Completion Date

April 14, 2024

Conditions

Penile CancerMargin Assessment

Interventions

DRUG

Cetuximab-IRDye800CW

Patients will receive 75mg Cetuximab followed by 15mg Cetuximab-IRDye800CW two days prior to surgery

Trial Locations (1)

9713GZ

University Medical Center Groningen, Groningen

Sponsors

Collaborators (1)

Erasmus Medical Center

All Listed Sponsors

collaborator

Erasmus Medical Center

OTHER

lead

University Medical Center Groningen

OTHER